Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 38,265 | 28,504 | 31,018 | 32,794 | 44,608 |
| Cost of Goods | 18,023 | 14,835 | 14,597 | 13,753 | 18,391 |
| Gross Profit | 20,242 | 13,669 | 16,421 | 19,041 | 26,217 |
| Operating Expenses | 31,524 | 34,116 | 34,286 | 39,114 | 43,512 |
| Operating Income | -11,259 | -19,612 | -17,268 | -19,320 | -16,904 |
| Interest Expense | 1,072 | 968 | 896 | 887 | 890 |
| Other Income | 2,088 | 5,315 | 504 | -285 | 755 |
| Pre-tax Income | -10,243 | -15,265 | -17,660 | -20,492 | -17,039 |
| Income Tax | -813 | -1,422 | -517 | -1,671 | 987 |
| Net Income Continuous | -9,430 | -13,843 | -17,143 | -18,821 | -18,026 |
| Net Income | $-9,430 | $-13,843 | $-17,143 | $-18,821 | $-18,026 |
| EPS Basic Total Ops | -0.12 | -0.18 | -0.23 | -0.25 | -0.25 |
| EPS Basic Continuous Ops | -0.12 | -0.18 | -0.23 | -0.25 | -0.24 |
| EPS Diluted Total Ops | -0.12 | -0.18 | -0.23 | -0.25 | -0.25 |
| EPS Diluted Continuous Ops | -0.12 | -0.18 | -0.23 | -0.25 | -0.24 |
| EBITDA(a) | $-7,179 | $-15,524 | $-13,290 | $-15,271 | $-12,613 |